Notice of clarification to drug manufacturers and sponsors: Canadian-specific considerations in risk management plans
Data and Resources
Additional Info
| Field | Value |
|---|---|
| Source | |
| Version | |
| Author | |
| Author Email | |
| Maintainer | |
| Maintainer Email | |
| Data Level | |
| Agreement Required | |
| Purpose Constraints | |
| Redistribution Allowed | |
| AI Training Allowed | |
| Data Steward | |
| Title (French) | Avis de clarification aux fabricants et aux promoteurs de médicaments : Considérations propres au contexte canadien dans les plans de gestion des risques |
| Update Frequency | as_needed |
| Geographic Scope | [] |
| Criticality Level | [] |
| Sensitivity Level | unrestricted |
| Language | |
| Contact Person | |
| Contact Email | |
| Data Dictionary | |
| Open Canada Date Published | 2020-11-09 00:00:00 |
| Open Canada Date Modified | |
| Open Canada Subject | ["health_and_safety"] |
| Open Canada Keywords | {"fr": ["Avis de clarification", "fabricants de médicaments", "promoteurs", "considérations spécifiques au Canada", "plans de gestion des risques", "certains produits médicamenteux"], "en": ["Notice of clarification", "drug manufacturers", "sponsors", "Canadian-specific considerations", "risk management plans", "certain drug products"]} |
| Open Canada Collection | publication |
| Principal Organization | |
| Reference Data | |
| Official Source |